Wolverine Trading
LJPC

Wolverine Trading’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Wolverine Trading’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-11,442
Closed -$48K – 5636
2020
Q1 		$48K Sell
11,442
-6,164
-35% -$38.9K ﹤0.01% 4276
2019
Q4 		$68K Buy
+17,606
New +$104K ﹤0.01% 4387
2018
Q3 		– Sell
-11,338
Closed -$338K – 6573
2018
Q2 		$338K Hold
11,338
– – ﹤0.01% 3613
2018
Q1 		$338K Buy
11,338
+539
+5% +$17.4K ﹤0.01% 3613
2017
Q4 		$348K Buy
+10,799
New +$353K ﹤0.01% 3413

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
KT
Kevin Tang $783 AUM 75.59% 1-Year Est. Return

Wolverine Trading's LJPC Position: Q2 2020 in Review

Wolverine Trading sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2020, closing a stake of 11,442 shares — an estimated $48K sold.

Wolverine Trading first reported a position in LJPC in Q4 2017 and held it in 5 quarters. The position peaked at $348K in Q4 2017. 76 funds tracked by Wall St. Rank hold LJPC as of Q2 2020.

  • Wolverine Trading reported no remaining La Jolla Pharmaceutical Company position as of Q2 2020 after selling out during the quarter.
  • Wolverine Trading sold 11,442 La Jolla Pharmaceutical Company shares in Q2 2020, an estimated $48K.
  • Wolverine Trading first reported a position in La Jolla Pharmaceutical Company in Q4 2017 and held it in 5 quarters.
  • Wolverine Trading's La Jolla Pharmaceutical Company position peaked at $348K in Q4 2017.
  • 76 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2020.

Based on Wolverine Trading's 13F filing for Q2 2020, filed 13 Aug 2020.